Pancreas Cancer
Conditions
Keywords
pancreatic neoplasms, neoplasms, registry, advanced pancreatic cancer, health services research, epidemiology, Germany, palliative treatment, palliative care, localized, resectable pancreatic cancer, adjuvant treatment
Brief summary
The registry aims to collect and analyse information on the antineoplastic treatment of patients with unresectable locally advanced or metastatic pancreatic cancer, treated in palliative intention (cohort 1) and patients with localized, resectable pancreatic cancer treated in neo-adjuvant or adjuvant intention (cohort 2) in daily routine practice in Germany. The registry will follow up patients for two years. It will identify common sequences of treatments used as well as changes in the treatment of the disease. Health-related quality of life will be analysed during the course of the treatment (PanLife). Based on the available data a prognostic score will be developed.
Interventions
None listed
Sponsors
iOMEDICO AG
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* resectable or locally advanced/metastatic pancreatic cancer * 18 years and older * Antineoplastic treatment * Date of consent no later than 2 weeks after start of first-line treatment
Exclusion criteria
* No pancreatic cancer * Below 18 years and older * No antineoplastic treatment * Date of consent later than 2 weeks after start of first-line treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Treatment reality in Germany | over 5 years | description of treatments selected for patients per line of therapy over the course of the project |
Countries
Germany
Outcome results
None listed